The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
Ceased 6
  • 1
    Moore-thornicroft, Storme
    Pa
    Individual (6 offsprings)
    Officer
    2002-03-12 ~ 2014-10-03
    OF - Secretary → CIF 0
  • 2
    De Vries, Sijmen, Dr
    Business born in October 1959
    Individual (1 offspring)
    Officer
    2002-07-24 ~ 2016-04-01
    OF - Director → CIF 0
  • 3
    Starr, Alison
    Solicitor born in July 1970
    Individual (1 offspring)
    Officer
    2002-03-07 ~ 2002-03-12
    OF - Director → CIF 0
  • 4
    Skinner, Jeffrey David
    Business Development born in February 1957
    Individual (3 offsprings)
    Officer
    2002-05-21 ~ 2008-01-17
    OF - Director → CIF 0
  • 5
    Mery, Stephane Robert George, Dr
    Business Development born in April 1965
    Individual (20 offsprings)
    Officer
    2002-07-24 ~ 2008-09-01
    OF - Director → CIF 0
  • 6
    Marks, Daniel Simon
    Individual
    Officer
    2002-03-07 ~ 2002-03-12
    OF - Secretary → CIF 0
parent relation
Company in focus

SYLUS PHARMACEUTICALS LTD

Standard Industrial Classification
86900 - Other Human Health Activities
Brief company account
Staff Costs/Employee Benefits Expense
-67,500 GBP2022-04-01 ~ 2023-03-31
Expenses related to depreciation, amortization, and impairment of assets
-1,557 GBP2023-04-01 ~ 2024-03-31
-2,253 GBP2022-04-01 ~ 2023-03-31
Profit/Loss
-154,017 GBP2023-04-01 ~ 2024-03-31
-85,900 GBP2022-04-01 ~ 2023-03-31
Fixed Assets
1,980 GBP2024-03-31
3,537 GBP2023-03-31
Current Assets
54,614 GBP2024-03-31
201,869 GBP2023-03-31
Creditors
Amounts falling due within one year
-2,950 GBP2024-03-31
-2,550 GBP2023-03-31
Net Current Assets/Liabilities
51,664 GBP2024-03-31
199,319 GBP2023-03-31
Total Assets Less Current Liabilities
53,644 GBP2024-03-31
202,856 GBP2023-03-31
Creditors
Amounts falling due after one year
-68,666 GBP2024-03-31
-63,862 GBP2023-03-31
Net Assets/Liabilities
-15,022 GBP2024-03-31
138,994 GBP2023-03-31
Equity
-15,022 GBP2024-03-31
138,994 GBP2023-03-31
Average Number of Employees
02023-04-01 ~ 2024-03-31

  • SYLUS PHARMACEUTICALS LTD
    Info
    Registered number 04389197
    2a Dunmore Court, Wootton Road, Abingdon OX13 6BH
    Private Limited Company incorporated on 2002-03-07 (23 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2024-03-06
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.